Celldex Therapeutics (CLDX) PT Lowered to $54 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $41.95 -1.55%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Kristen Kluska lowered the price target on Celldex Therapeutics (NASDAQ: CLDX) to $54.00 (from $55.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
- CAE Inc. (CAE:CN) (CAE) PT Raised to Cdn$49 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
